ATH Alterity Therapeutics Ltd

By Kathryn Hardison

International stocks trading in New York closed higher on Friday.

The S&P/BNY Mellon index of American depositary receipts increased 2.2% to 148.13. The European index increased 2.2% to 142.58, the Asian index rose 2% to 173.46, the Latin American index increased 2.8% to 185.88 and the emerging markets index gained 1.9% to 291.58.

Shell PLC and Eisai Co. were among the companies with ADRs that traded actively.

ADRs of Shell rose 3.2% after the oil giant said it expects its quarterly natural-gas profit was "significantly higher" than in the preceding three months when price swings curbed results in that core business. It also expects to pay around $2 billion more in European Union and U.K. energy-profit levies.

ADRs of Eisai increased 4.1% after the Food and Drug Administration approved lecanemab, a new drug promising to slow Alzheimer's disease created by Eisai and partner Biogen Inc.

ADRs of Alterity Therapeutics fell 5% after the biotechnology company's board of directors approved a 1-for-10 reverse ADS split.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

January 06, 2023 17:05 ET (22:05 GMT)

Alterity Therapeutics (ASX:ATH)
Historical Stock Chart
From Oct 2024 to Nov 2024

Alterity Therapeutics (ASX:ATH)
Historical Stock Chart
From Nov 2023 to Nov 2024